Bruneau Aure 4

Accession 0000911916-19-000184

CIK 0001136869other

View on SEC.gov Company Profile

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 4:48 PM ET

Size

31.6 KB

Accession

0000911916-19-000184

Insider Transaction Report

Form 4

Period: 2019-11-11

ZIMMER BIOMET HOLDINGS, INC.ZBH

Bruneau Aure

Group President

Transactions

Exercise/Conversion
Common Stock
2019-11-11$104.01/sh+4,718$490,719→ 5,475 total
Sale
Common Stock
2019-11-11$141.47/sh−1,613$228,199→ 757 total
Sale
Common Stock
2019-11-11$141.17/sh−2,910$410,799→ 757 total
Exercise/Conversion
Common Stock
2019-11-11$114.44/sh+2,780$318,143→ 3,537 total
Exercise/Conversion
Employee Stock Option (right to buy)
2019-11-11−3,150→ 0 total
Exercise: $113.83Exp: 2025-06-24→ Common Stock (3,150 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2019-11-11−2,910→ 2,910 total
Exercise: $121.88Exp: 2027-03-21→ Common Stock (2,910 underlying)
Exercise/Conversion
Common Stock
2019-11-11$113.83/sh+3,150$358,565→ 3,907 total
Sale
Common Stock
2019-11-11$141.24/sh−4,718$666,384→ 757 total
Exercise/Conversion
Common Stock
2019-11-11$103.25/sh+1,613$166,542→ 2,370 total
Exercise/Conversion
Common Stock
2019-11-11$121.88/sh+2,910$354,671→ 3,667 total
Sale
Common Stock
2019-11-11$141.14/sh−2,780$392,369→ 757 total
Exercise/Conversion
Employee Stock Option (right to buy)
2019-11-11−4,718→ 1,572 total
Exercise: $104.01Exp: 2026-03-21→ Common Stock (4,718 underlying)
Sale
Common Stock
2019-11-11$141.31/sh−3,150$445,114→ 757 total
Exercise/Conversion
Employee Stock Option (right to buy)
2019-11-11−1,613→ 1,612 total
Exercise: $103.25Exp: 2027-01-03→ Common Stock (1,613 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2019-11-11−2,780→ 8,340 total
Exercise: $114.44Exp: 2028-03-20→ Common Stock (2,780 underlying)

Footnotes (10)

[F1]Represents the sale of 3,150 shares in multiple transactions ranging in price from $140.98 to $141.595 per share, resulting in a weighted average sale price of $141.306. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
[F10]2,780 options vested on March 20, 2019; and the remaining unvested options will vest in equal portions on each of March 20, 2020, March 20, 2021 and March 20, 2022.
[F2]Represents the sale of 4,718 shares in multiple transactions ranging in price from $141.005 to $141.64 per share, resulting in a weighted average sale price of $141.243. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
[F3]Represents the sale of 1,613 shares in multiple transactions ranging in price from $141.00 to $141.72 per share, resulting in a weighted average sale price of $141.475. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
[F4]Represents the sale of 2,910 shares in multiple transactions ranging in price from $141.065 to $141.505 per share, resulting in a weighted average sale price of $141.168. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
[F5]Represents the sale of 2,780 shares in multiple transactions ranging in price from $140.995 to $141.59 per share, resulting in a weighted average sale price of $141.14. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
[F6]One-fourth of the options vested on each of June 24, 2016, June 24, 2017, June 24, 2018 and June 24, 2019.
[F7]4,718 of the options vested in thirds on each of March 21, 2017, March 21, 2018 and March 21, 2019; and the remaining unvested options will vest on March 21, 2020.
[F8]806 options vested on January 3, 2018; 807 options vested on January 3, 2019; and the remaining unvested options will vest in equal portions on each of January 3, 2020 and January 3, 2021.
[F9]1,455 options vested on each of March 21, 2018 and March 21, 2019; and the remaining unvested options will vest in equal portions on each of March 21, 2020 and March 21, 2021.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

ZIMMER BIOMET HOLDINGS, INC.

CIK 0001136869

→

Entity typeother

Related Parties

filerCIK 0001725831

Filing Metadata

Form type: 4
Filed: Nov 12, 7:00 PM ET
Accepted: Nov 13, 4:48 PM ET
Size: 31.6 KB

View on SEC.gov